- Home
- RBBN vs MYGN Comparison
RBBN vs MYGN Comparison
Compare RBBN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBBN
- MYGN
- Stock Information
- Founded
- RBBN 1997
- MYGN 1991
- Country
- RBBN United States
- MYGN United States
- Employees
- RBBN N/A
- MYGN N/A
- Industry
- RBBN EDP Services
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RBBN Technology
- MYGN Health Care
- Exchange
- RBBN Nasdaq
- MYGN Nasdaq
- Market Cap
- RBBN 671.1M
- MYGN 642.0M
- IPO Year
- RBBN 2000
- MYGN 1995
- Fundamental
- Price
- RBBN $3.76
- MYGN $7.64
- Analyst Decision
- RBBN Strong Buy
- MYGN Hold
- Analyst Count
- RBBN 4
- MYGN 13
- Target Price
- RBBN $6.00
- MYGN $13.50
- AVG Volume (30 Days)
- RBBN 559.5K
- MYGN 1.5M
- Earning Date
- RBBN 10-22-2025
- MYGN 11-06-2025
- Dividend Yield
- RBBN N/A
- MYGN N/A
- EPS Growth
- RBBN N/A
- MYGN N/A
- EPS
- RBBN N/A
- MYGN N/A
- Revenue
- RBBN $863,459,000.00
- MYGN $832,900,000.00
- Revenue This Year
- RBBN $7.26
- MYGN $0.17
- Revenue Next Year
- RBBN $5.52
- MYGN $6.19
- P/E Ratio
- RBBN N/A
- MYGN N/A
- Revenue Growth
- RBBN 7.68
- MYGN 3.83
- 52 Week Low
- RBBN $3.01
- MYGN $3.76
- 52 Week High
- RBBN $5.38
- MYGN $26.52
- Technical
- Relative Strength Index (RSI)
- RBBN 44.08
- MYGN 57.10
- Support Level
- RBBN $3.73
- MYGN $7.04
- Resistance Level
- RBBN $3.98
- MYGN $8.25
- Average True Range (ATR)
- RBBN 0.10
- MYGN 0.38
- MACD
- RBBN -0.01
- MYGN -0.06
- Stochastic Oscillator
- RBBN 20.07
- MYGN 54.77
About RBBN Ribbon Communications Inc.
Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.